20 Chapter 1 rodent animal model. Clin Exp Metastasis 2023, 40:243-53. [42] Wintjens A, Simkens GA, Fransen PKH, Serafras N, Lenaerts K, Franssen G, de Hingh I, Dankers PYW, Bouvy ND, Peeters A: Intraperitoneal drug delivery systems releasing cytostatic agents to target gastro-intestinal peritoneal metastases in laboratory animals: a systematic review. Clin Exp Metastasis 2022, 39:541-79. [43] Wintjens A, Fransen PKH, Lenaerts K, Liu H, van Almen GC, van Steensel S, Gijbels MJ, de Hingh I, Dankers PYW, Bouvy ND: Development of a Supramolecular Hydrogel for Intraperitoneal Injections. Macromol Biosci 2023:e2300005. [44] Pedrazzani C, Turri G, Marrelli D, Kim HJ, Park EJ, Spolverato G, Foppa C, Spinelli A, Pucciarelli S, Baik SH, Choi GS: Prediction of Metachronous Peritoneal Metastases After Radical Surgery for Colon Cancer: A Scoring System Obtained from an International Multicenter Cohort. Ann Surg Oncol 2022, 29:7896-906. [45] Tsai TY, You JF, Hsu YJ, Jhuang JR, Chern YJ, Hung HY, Yeh CY, Hsieh PS, Chiang SF, Lai CC, Chiang JM, Tang R, Tsai WS: A Prediction Model for Metachronous Peritoneal Carcinomatosis in Patients with Stage T4 Colon Cancer after Curative Resection. Cancers (Basel) 2021, 13. [46] Ogunwobi OO, Mahmood F, Akingboye A: Biomarkers in Colorectal Cancer: Current Research and Future Prospects. Int J Mol Sci 2020, 21.
RkJQdWJsaXNoZXIy MTk4NDMw